Xencor stock surges on positive cancer drug trial data
Summary
Investing.com reports that Xencor's stock surged after positive data from a cancer drug trial. The article is known only from its headline, so it gives no further details on the trial or the size of the share move.
Timeline
Investing.com
Source ↗Investing.com reports that Xencor's stock surged on positive cancer drug trial data.
Comments
No comments yet.
to like and comment.